Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
ImmuneOnco Biopharmaceuticals’ HK$319 Million IPO
Laekna’s HK$791 Million Initial Public Offering
Davis Polk, Jingtian & Gongcheng and Harney Westwood advised Laekna, while Cooley and Commerce & Finance Law Offices advised the sole sponsor and the underwriters. Laekna,...
Cutia Therapeutics’ IPO on Hong Kong Market
Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on the listing. Cutia Therapeutics, a company with operations in Beijing, Hong Kong, Shanghai,...
YSB Inc’s IPO
Freshfields has provided Hong Kong and US law advice to the sole sponsor, sole overall coordinator and underwriters in the global offering and listing of shares...
Mobileye’s $1.617 Billion Secondary Offering
Davis Polk & Wardwell LLP advised Mobileye Global Inc on the offering, while Sullivan & Cromwell LLP advised the underwriters. Mobileye Global Inc., a leader of the...
Edianyun Limited’s Hong Kong IPO
Harneys acted as Cayman Islands counsel to Edianyun Limited on the transaction, while Wilson Sonsini Goodrich & Rosati acted as U.S. and Hong Kong counsel to...
Beisen’s Hong Kong Listing
Paul Hastings LLP advised Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities Limited on the deal. Morgan Stanley Asia Limited and China...
MedSci Healthcare Holdings Limited’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills has advised China International Capital Corporation Hong Kong Securities Limited, and Macquarie Capital Limited. MedSci Healthcare operates one of the largest online professional...
QuantaSing’s $40 Million IPO
Wilson Sonsini represented QuantaSing, while Latham & Watkins advised the joint bookrunners on the offering. QuantaSing Group Limited announced the pricing of its initial public offering...
Fenbi’s HK$198 Million Listing on The HKSE
Cooley advised the underwriters involved in the listing while Wilson Sonsini Goodrich & Rosati represented Fenbi. Fenbi, an internet-born test preparation company, proposed the listing of...
Shanghai Chicmax Cosmetic Co., Ltd.’s US$141.5 Million Initial Public Offering on the HKSE
Clifford Chance and JunHe advised cosmetics company Shanghai Chicmax Cosmetic Co., Ltd. on the deal. Freshfields Bruckhaus Deringer advised the joint sponsors. Shanghai Chicmax Cosmetic Co.,...
OrbusNeich Medical Group’s Initial Public Offering
Baker McKenzie advised the underwriters on the deal. OrbusNeich Medical Group executed an initial public offering. OrbusNeich Medical is a major global medical device manufacturer specializing...